This opportunity is no longer accepting applications.
grant RFA-CA-24-029

RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical Trial Not Allowed)

This grant aims to support research exploring how RNA modifications contribute to cancer development, particularly through changes in protein production within cells. It focuses on understanding how modifications in different types of RNA (mRNA, tRNA, and rRNA) influence cancer progression and response to treatment. Since this area is complex, involving interactions between various RNA modific…

The overarching objective of this concept is to promote mechanistic research in the emerging area of RNA modifications that drive oncogenesis, with a focus on the central role of RNA modifications in translational reprogramming of cancer cells. RNA modifications have been recognized to exert a s…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: July 29, 2024
Application Window Closes: November 4, 2024
Open for Submission: July 29, 2024
Submission Deadline: November 4, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.